Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.44 USD | -2.73% | -2.21% | +13.55% |
Financials (USD)
Sales 2024 * | 141M | Sales 2025 * | 314M | Capitalization | 3.07B |
---|---|---|---|---|---|
Net income 2024 * | -333M | Net income 2025 * | -245M | EV / Sales 2024 * | 20.9 x |
Net cash position 2024 * | 123M | Net cash position 2025 * | 399M | EV / Sales 2025 * | 8.51 x |
P/E ratio 2024 * |
-9.04
x | P/E ratio 2025 * |
-11.8
x | Employees | 305 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.5% |
Latest transcript on SpringWorks Therapeutics, Inc.
1 day | -2.73% | ||
1 week | -2.21% | ||
Current month | -0.04% | ||
1 month | -11.23% | ||
3 months | -15.86% | ||
6 months | +36.38% | ||
Current year | +13.55% |
Managers | Title | Age | Since |
---|---|---|---|
Saqib Islam
CEO | Chief Executive Officer | 54 | 17-07-31 |
Daniel Lynch
CHM | Chairman | 65 | 15-12-31 |
Frank Perier
DFI | Director of Finance/CFO | 64 | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Fuhrman
BRD | Director/Board Member | 67 | 19-07-31 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 17-07-31 |
Carlos Alban
BRD | Director/Board Member | 61 | 22-07-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.10% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% | ||
0.07% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 41.46 | -2.70% | 897,157 |
24-05-30 | 42.61 | +4.28% | 548,631 |
24-05-29 | 40.86 | -3.43% | 562,189 |
24-05-28 | 42.31 | -0.17% | 871,589 |
24-05-24 | 42.38 | -1.00% | 633,710 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.55% | 3.07B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- SWTX Stock